Diagnostic Imaging Devices - Benelux

The projected revenue in the Diagnostic Imaging Devices market market in Benelux is set to reach US$975.90m in 2024.
It is expected that the revenue will demonstrate an annual growth rate (CAGR 2024-2029) of 4.02%, leading to a market volume of US$1.19bn by 2029.
When compared globally, the United States will generate the highest amount of revenue, reaching US$11.93bn in 2024.
Benelux's diagnostic imaging market is witnessing a surge in demand for advanced ultrasound devices for prenatal screenings.

Definition:
The market covers diagnostic imaging devices such as X-ray systems, ultrasound systems, computed tomography scanners, Magnetic resonance imaging (MRT) systems, and related components.

Additional information:
Market values represent revenues paid to primary vendors at manufacturer price level either directly or through distribution channels (excluding VAT). Reported market revenues include spending by consumers (B2C), enterprises (B2B) as well as governments (B2G). Revenues are allocated to the country where the money is spent.

Company examples: Siemens Healthineers, General Electric, Philips, Fujifilm Holdings. Further information on the key players can be found in the Market Shares boxes.

X-ray systems
Computed tomography (CT) scanners
Magnetic resonance imaging (MRT) systems
Positron emission tomography (PET) scanners

Non-imaging diagnostics
In vitro diagnostics (IVD)

The Diagnostic Imaging Devices market in Benelux is experiencing significant growth due to a combination of customer preferences, trends in the market, local special circumstances, and underlying macroeconomic factors. Customer preferences in the Benelux region have played a key role in driving the growth of the Diagnostic Imaging Devices market. Patients and healthcare professionals in Benelux countries, Belgium, the Netherlands, and Luxembourg, have shown a strong preference for advanced imaging technologies that provide accurate and detailed diagnostic information. This has led to a higher demand for diagnostic imaging devices such as MRI scanners, CT scanners, ultrasound systems, and X-ray machines. Trends in the market have also contributed to the growth of the Diagnostic Imaging Devices market in Benelux. Technological advancements in imaging devices have made them more efficient, accurate, and user-friendly. For example, the development of digital imaging technology has revolutionized the field of diagnostic imaging by providing high-resolution images and reducing the need for film and chemicals. Additionally, the increasing adoption of telemedicine and remote monitoring has created a demand for portable and mobile imaging devices that can be used in remote or underserved areas. Local special circumstances in Benelux have further fueled the growth of the Diagnostic Imaging Devices market. The region has a well-developed healthcare infrastructure with a high level of healthcare expenditure. This has enabled healthcare providers to invest in advanced imaging technologies and upgrade their existing equipment. Furthermore, the Benelux countries have a high prevalence of chronic diseases such as cardiovascular diseases and cancer, which require frequent diagnostic imaging procedures. This has contributed to the increased demand for diagnostic imaging devices in the region. Underlying macroeconomic factors have also played a role in the growth of the Diagnostic Imaging Devices market in Benelux. The region has a stable and prosperous economy, which has resulted in increased healthcare spending. Additionally, favorable government policies and initiatives to improve healthcare infrastructure and access to healthcare services have created a conducive environment for the growth of the Diagnostic Imaging Devices market. In conclusion, the Diagnostic Imaging Devices market in Benelux is experiencing significant growth due to customer preferences for advanced imaging technologies, trends in the market such as technological advancements and the increasing adoption of telemedicine, local special circumstances including a well-developed healthcare infrastructure and a high prevalence of chronic diseases, and underlying macroeconomic factors such as a stable economy and favorable government policies.

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on medical devices and IVD revenues allocated to the country where the money is spent at manufacturer price levels excluding VAT.

Modeling approach / Market size:

Modeling employs a top-down approach with a bottom-up validation, using financial information of the key players by market. Market sizes are determined by a top-down approach, based on a specific rationale for each market market and allocated to the covered countries according to the global market shares. As a basis for evaluating markets, we use relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare system, and regulations concerning medical products. Next, we use further relevant key market indicators and data from country-specific associations, such as healthcare expenditure per capita, health risk factors, healthcare payer system, and regulations concerning medical products. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Medical technology plays a role in the lives of everyone. It includes most of all, medical devices which simplify the prevention, diagnosis, and treatment of diseases and illnesses. The most well-known medical technology products are, among others, pacemakers, imaging instruments, dialysis machines, and implants. The global medical technology industry was worth over 567 billion U.S. dollars annually. Established centers of this industry include North America and Western Europe. The United States is home to the world’s largest medical technology companies. As of 2022, Abbott Laboratories had the largest global revenue at over 31.2 billion U.S. dollars. The main focus of devices manufactured by the Chicago-based company are diagnostics, cardiovascular, and diabetes care. Two other medtech companies that round off the top three largest companies –Medtronic and Johnson & Johnson – are both based in the United States. Although, industry trends show that Asia, and in particular China, is about to play a more prominent role in the years to come.